Eloralintide, a selective, long‐acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept - Bhattachar - 2026 - Diabetes, Obesity and Metabolism US$ 23.74 Min. order: 1 piece ★★★★★ 4.5 (270 reviews) Sold : Login>>
Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management US$ 26.02 Min. order: 1 piece ★★★★★ 4.7 (169 reviews) Sold : Login>>
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 US$ 24.93 Min. order: 1 piece ★★★★★ 4.2 (218 reviews) Sold : Login>>
Musculoskeletal and Tissue Healing with BPC 157: Weight Loss and Vitality: Medical Weight Loss US$ 20.00 Min. order: 1 piece ★★★★★ 4.9 (121 reviews) Sold : Login>>